Introduction
The female reproductive tract has the specialized duties of permitting or facilitating transport of spermatozoa, fertilized eggs and the developing embryo. It also must provide an environment to maintain the developing embryo. At parturition, these same tissues must support fetal delivery. Multiple tissues are involved, i.e. oviduct, uterus, cervix and vagina, each with specialized functions as well as specialized structure and physiology to support these functions. The female reproductive tract also shares many of the challenges of other mucosa in that it must provide a barrier to enzymatic and microbial attack. Typically, reduction or loss of mucosal barrier function leads to inflammation or infection. In the case of the reproductive tract, these conditions can severely compromise the reproductive potential of the animal (Zahl and Bjerknes, 1943; Coid, 1976; Gower et al., 1990 ). This article emphasizes recent studies describing the expression and function of high molecular weight mucin glycoproteins, particularly Muc-1, in the female reproductive tract. These studies indicate that such glycoproteins not only protect the reproductive tract from microbial challenge, but also play a critical role in the reproductive process itself.
The implantation process
Implantation is the process by which mammalian embryos and maternal tissue intimately interact in a way that will ultimately lead to the formation of a placenta. The strategy for creating a placenta and other aspects of the implantation process vary considerably among species (Benirshke, 1983) ; however, a common feature is the interaction, i.e. physical contact, between the trophectodermal cells of the embryo and the apical surface of the uterine epithelium. Following fertilization, the embryo undergoes a series of cell divisions which lead to the formation of two tissue types at the blastocyst stage, namely, the pluripotential cells of the inner cell mass and the differentiated cells of the trophectoderm. This development occurs as the zygote is transported through the relatively narrow passage of the oviduct. Impairment of this process can lead to one common form of ectopic pregnancy (Russell, 1987) . After arrival in the uterus, the blastocyst hatches from the zona pellucida. The ability to attach to the uterine surface appears to follow the hatching process, since blastocysts that have had their zonae prematurely removed are not attachment-competent (Sherman and Wudl, 1976) . Furthermore, implantation delay results in embryos which have hatched, but fail to implant, indicating that these processes are developmentally distinct. At the initial phase of implantation, the external plasma membrane of trophectodermal cells establishes contact with the apical surface of the uterine epithelium. Various classes of adhesion molecules have been identified on the trophectodermal surface, including heparan sulphate proteoglycans (Farach et al., 1987; Smith et al., 1997) , integrins (Armant et al., 1986) and carbohydrate binding sites (Lindenberg et al., 1990) .
In parallel with the development of the embryo, the uterus also must develop to a state where it permits blastocyst attachment. This process is normally co-ordinated by the program of steroid hormones elaborated by the corpus luteum. These hormones may exert effects on the uterine epithelium either directly through activation of epithelial steroid hormone receptors or indirectly through non-epithelial cells, e.g. stroma, which, in turn, produce growth factors, cytokines or other lipid hormones which act upon the epithelium. It is not completely clear which actions of steroid hormones are direct or indirect upon the epithelium; however, the availability of oestrogen receptor-α (Lubahn et al., 1993) and progesterone receptor (Lydon et al., 1995) null mice as well as the ability to recombine epithelial and stromal tissues (Cunha and Young, 1992) provides an opportunity to resolve the actions of these hormones on many individual processes. Regardless of whether their actions are direct or indirect, it is clear that steroid hormones dramatically influence the behaviour of reproductive tract epithelium. Of particular relevance to implantation are the observations of cytoskeletal reorganization and reduction of the apical glycocalyx of uterine epithelium in many species (Schlafke and Enders, 1975; Murphy, 1993) . These alterations are expected to have important consequences for embryo-uterine interactions.
Mucins in the uterine epithelium
With the exception of a few scattered reports (Anderson et al., 1986; Svalander et al., 1990) , identification of the molecular components of the apical surface of the uterine epithelium has been elusive. In large part, this is due to the difficulty in studying this surface by standard methods of protein vectorial labelling and analyses. In the pig, Mullins et al. (1980) were successful using carbohydrate-directed methods to label epithelial plasma membrane components. The development of techniques for the polarized culture of uterine epithelium (Glasser et al., 1988) provided a new opportunity to examine not only vectorially secreted products of these cells, but also for analysing the apical cell surface components. As a result, large molecular weight mucin-type glycoproteins were identified as major glycoconjugate components of uterine epithelial cells and cell surfaces (Mani et al., 1992; Valdizan et al., 1992) . Mucins are defined as glycoproteins substituted with oligosaccharides linked to serine or threonine residues in proteins (Strous and Dekker, 1992) . Mucin core proteins are usually fairly large (1-500 kDa) and can contain hundreds of O-linked oligosaccharides. The vast amounts of these oligosaccharides generate a large hydration sphere and give these glycoproteins unique properties, including resistance to enzymatic attack (Jentoft, 1990; Strous and Dekker, 1992) . These properties account for the barrier functions generally attributed to mucins (Jentoft, 1990; Hilkens et al., 1992) .
Biochemical characterization of cell surface mucins produced by polarized mouse uterine epithelial cells indicated that they have the characteristics of integral membrane proteins (Valdizan et al., 1992) . One transmembrane mucin glycoprotein found in many simple epithelia is Muc-1 (Pemberton et al., 1992) . Muc-1 expression by mouse uterine epithelia was confirmed both in vitro (Pimental et al., 1996) and in vivo (Braga and Gendler, 1993; Surveyor et al., 1995) . As is the case for many other uterine glycoconjugates (Carson et al., 1990) , Muc-1 expression is strongly influenced by steroid hormones in mice and other species (Surveyor et al., 1995; Bowen et al., 1996; Hild-Petito et al., 1996; Hoffman et al., 1998) . Hormonal control over Muc-1 expression is discussed in detail below.
As mentioned above, mucins are generally thought to function as barrier molecules. In this capacity, mucins have been shown to provide protection from enzymatic and microbial attack (Jentoft, 1990) . In this regard, inhibition of mucin assembly increases the sensitivity of uterine epithelia to proteolytic attack (Valdizan et al., 1992) . Other studies indicate that Muc-1 has immunosuppressive activity, although the mechanism for this effect is unclear (Gimmi et al., 1996) . High level mucin expression has been shown to inhibit both cell-cell and cell-extracellular matrix adhesion in several systems (Hilkens et al., 1992) .
Polarized uterine epithelia remain persistently non-receptive in vitro Valdizan et al., 1992) and express high levels of mucins (Mani et al., 1992; Pimental et al., 1996) . Several types of studies indicate that mucins function to prevent embryo attachment to uterine epithelia (DeSouza et al., 1999) . First, selective, enzymatic removal of mucins from the apical cell surface of polarized uterine epithelia converts these cells from their normally non-receptive to a functionally receptive state. Second, uterine epithelia derived from Muc-1 null mice are chronically receptive in vitro. Third, adhesion of cells that overexpress Muc-1 to attachment-competent mouse blastocysts is greatly reduced in comparison to their non-Muc-1 expressing revertants.
From the above studies, it is expected that high level expression of mucins such as Muc-1 by the luminal uterine epithelium would create a non-receptive surface with regard to embryo attachment. Consistent with this hypothesis are the observations in many species that Muc-1 is generally reduced in the luminal epithelium during conversion to a receptive state. These species include mice (Braga and Gendler, 1992; Surveyor et al., 1995) , baboons (Hild-Petito et al., 1996) , pigs (Bowen et al., 1996) and rats (DeSouza et al., 1998) . An important consideration is that general reduction of Muc-1 expression in luminal uterine epithelia is not necessarily required for implantation to occur. In rabbits, Muc-1 protein and mRNA are actually greatly elevated in the uterus during conversion to a receptive state; however, Muc-1 protein and mRNA are reduced locally at implantation sites, suggesting that embryonic signals trigger Muc-1 loss (Hoffman et al., 1998) . In women, MUC1 (human nomenclature) persists in lumenal epithelia during transition to a receptive state, i.e. mid-luteal phase (Hey et al., 1994) . For ethical reasons, it is not possible to determine if MUC1 is locally reduced at human implantation sites. Nonetheless, there are some clues that aspects of MUC1 expression change during the receptive phase. Using a combination of antibodies that recognize all forms of MUC1 with glycosylation variant (glycoform)-specific antibodies, we determined that particular MUC1 glycoforms are distributed in a regional and cycle-dependent fashion (DeLoia et al., 1998) . These studies indicate that MUC1 glycoform switching is particularly evident in the luminal epithelium. Whether or not uterine glycoform switching impacts MUC1 function is unclear. Such switches may simply reflect differential hormonal influences on glycosyltransferase activities (Carson et al., 1990 and refs. within) which circumstantially alter MUC1 oligosaccharide structure. It also is possible that particular MUC1 glycoforms are pro-adhesive, e.g. LNF-1-bearing (Lindenberg et al., 1990) or selectin ligands (Laskey, 1992) , which might actually facilitate embryo attachment. While not necessarily glycoform-dependent, MUC1 associations with intracellular proteins, e.g. β-catenin (Yamomoto et al., 1997) , also may change during the menstrual cycle. Such changes may be associated with alterations in cytoskeletal associations or signal transduction pathways that, in turn, may influence the ability of MUC1 to function as a barrier to blastocyst attachment. For instance, reduced association with the cytoskeleton could expose cytoplasmic domains of MUC1 and trigger catabolism or release (Boshell et al., 1992; Pimental et al., 1996) . Alternatively, signal transduction cascades might be altered which result in enhanced mucin degradation, release or gene expression (Wegner et al., 1997) .
Hormonal control of Muc-1 expression
The dramatic changes in Muc-1 expression observed during the oestrus cycle in several species suggest that steroid hormones modulate this process. In pigs and rabbits, uterine epithelial cell mucin biosynthesis and Muc-1 expression are markedly up-regulated by progesterone in vitro and in vivo (Mani et al., 1992; Bowen et al., 1996 Bowen et al., , 1997 Hoffman et al., 1998) . A similar response to progesterone is observed in baboons; however, the effects of progesterone in this species are complex since Muc-1 expression markedly declines during the mid-luteal phase, a progesterone-dominated state (Hild-Petito et al., 1996) . Oestrogen alone seems to have relatively little effect on Muc-1 expression in this species.
Steroid hormone control of Muc-1 expression has been best studied in mice. It is possible that Muc-1 degradation is enhanced during conversion to a receptive state in vivo. Nonetheless, the half-life of Muc-1 determined in polarized mouse uterine epithelial cells in vitro is sufficiently short to account for its observed loss during the preimplantation period if further Muc-1 synthesis is stopped (Pimental et al., 1996) . Consistent with this, Muc-1 mRNA concentrations decline 10-20-fold during this interval (Surveyor et al., 1995) . This reduction in Muc-1 mRNA expression is accounted for by steroid hormone actions. Oestrogen, but not progesterone, strongly stimulates Muc-1 expression; however, progesterone antagonizes the stimulatory actions of oestrogen and is, therefore, dominant in this regard (Surveyor et al., 1995) . Both oestrogen and progesterone actions on Muc-1 expression are mediated by nuclear steroid hormone receptors. Pure anti-oestrogens (ICI 164, 384) inhibit oestrogen-driven Muc-1 expression. Furthermore, treatment of mice with the antiprogestin Figure 1 . The model emphasizes the functions and changes in expression of high molecular weight mucins (centipede-like structures) at the apical surfaces of reproductive tract mucosa. Upper left: Under most conditions, non-adhesive mucins are abundantly expressed at these surfaces and protect the mucosa from enzymatic attack, microbial adhesion and prevent embryo attachment. Upper right: Mucin loss may be triggered by steroid hormones or embryo-derived factors in the uterus to generate a surface receptive to embryo attachment. Lower left: In some species, it is possible that mucin oligosaccharide structures are altered such that the mucin can now function to promote embryo attachment. Lower right: In addition to facilitating embryo attachment, mucin loss also increases susceptibility to bacterial infection, presumably by increasing access to bacterial adhesion sites, in reproductive tract tissues.
RU486 not only restores uterine Muc-1 expression during the implantation period, but also inhibits implantation (Vinisanum and Martin, 1990) .
Consistent with the large effects of steroid hormones on uterine Muc-1 expression, the 1800 bp murine Muc-1 promoter contains several potential oestrogen and progesterone response elements (Vos et al., 1991; X.Zhou, M.M.DeSouza and D.D.Carson, unpublished studies) . Functional studies of this promoter should reveal if either oestrogen or progesterone receptors directly regulate this gene. These actions again may be complex. Both vaginal and cervical epithelial cells express Muc-1 and steroid hormone receptors; however, Muc-1 expression does not appear to change in these reproductive tract epithelia during conversion to a receptive uterine state. Thus, it is possible that tissue-specific transcription factors may be responsible for Muc-1 regulation and either function independently of or in co-operation with steroid hormone receptors. Further evidence in support of this concept comes from the observation that Muc-1 expression in murine mammary gland epithelia is high during lactation, a progesterone-dominated state (Parry et al., 1992) .
Muc-1 functions in cervix and vagina
The observation that Muc-1 expression persists in the cervix and vagina when expression in the uterus declines dramatically not only suggests distinct regulation of the Muc-1 gene in these tissues, but also a different functional requirement. These tissues, being in closer physical proximity to the external environment, also are expected to be presented with more environmental challenges, e.g. infection. Consistent with this notion is the observation that reproductive tract tissues of Muc-1 null mice are particularly susceptible to bacterial infections (DeSouza et al. 1999) . In contrast, these mice do not display infections with common murine viruses or Mycoplasma species. Reproductive tract tissues display mucins in addition to Muc-1 (Gollub et al., 1993; Kliman et al., 1995; Cruz et al., 1996; Gipson et al, 1997) . In fact, in mouse uterine epithelial cells, Muc-1 only accounts for ~10% of the total mucin complement (Pimental et al., 1996) . Thus, it is surprising that lack of expression of this quantitatively minor mucin has such a severe effect on resistance to infection.
Many bacterial adhesins recognize carbohydrate structures found on mucins (Venegas et al., 1995; Finlay and Cossart, 1997) . In the case of soluble mucins, binding is thought to 'trap' bacteria in the extracellular mass which is then flushed from the system; however, in the case of a transmembrane mucin such as Muc-1, binding would physically attach bacteria to the cell. This might be expected to increase the risk of infection. It is possible that binding activates mechanisms that normally release the extracellular domain of Muc-1. It is not clear if binding or cross-linking of Muc-1 at the cell surface signals release of the extracellular domain. Increased release of Muc-1 would have to be accompanied by an increased rate of replacement to avoid depletion of Muc-1 at this surface. Stimulation of an inflammatory response by infection could be a mechanism for replenishing Muc-1 in reproductive tract mucosa. In this regard, some evidence indicates that pro-inflammatory cytokines stimulate Muc-1 expression (Clark et al., 1994) .
Summary and future directions
Recent studies indicate that mucin glycoproteins constitute a large proportion of the apically disposed components of reproductive tract mucosa. The transmembrane mucin Muc-1 is found throughout the female reproductive tract in many species. As summarized in Figure 1 , loss of mucins such as Muc-1 appears to be required to generate a uterine epithelial surface that will permit embryo attachment. In many species, loss of Muc-1 appears to be driven by ovarian steroids. In others, embryonic signals may trigger this process. It also is possible that mucin oligosaccharide structures are altered during conversion to a receptive uterine state such that they can bind corresponding oligosaccharide receptors on blastocyst surfaces. Mucin expression is regulated differently in other reproductive tract tissues, i.e. cervix and vagina. In mice, Muc-1 is expressed persistently in these other tissues. Thus, mucin expression is differentially controlled in different hormonally responsive tissues of the female reproductive tract, indicating the presence of tissue-specific factors. Genetic ablation of Muc-1 predisposes mice to bacterial infections in the cervix and vagina. Consequently, Muc-1 appears to play important roles in both normal reproductive functions and in protection from bacterial pathogenesis.
